get a key
steadybase-$ company VNRX
account_id none on file
legal_name Volitionrx Ltd
ticker VNRX
cik 93314
domain volition.com
entry_point_account_id none on file
name VolitionRX Limited
exchange NYSE
sector Health Care
hq Henderson, NV, United States
calls 2 filings 1 executives 7 family 0
why_nownone on file
calls
Yeah, so we have planned for a lower level of spending this year. So if you remember last year, we had quite a lot of launches in the year, so spending was naturally higher at that point. And now it's, to a certain extent, it's sort of baked into business as usual. So yes, we will continue to attend conferences, particularly those where our partners are present. And if we need to, we will spend money. So it may well be lumpy from one quarter to the next. But overall, we've budgeted to spend less money this year versus last year.

May 16, 2025 / receipt, needs a key / Stephen, other | earnings call 2025-05-16 | transcript f55303a3-f66a-41ca-b3d6-f0c522e4adf8 | chars 23466-24000 | segment 24

One thing I would add as well, Stephen, in terms of what we're doing to try and save money, is we're attending the conferences to do the networking and meet with the KOLs. but we're not necessarily hiring a booth, because that's often what is the costly item at a conference. So that's definitely helped us manage costs, but we are still active. So for example, Dr. Retta and Dr. Terry Kelly are attending ATS this weekend, the American Thoracic Society, but we don't have a booth at that. So then the costs are limited to just registration and then kind of some of the networking costs. So that's a way that we've kind of clawed back.

May 16, 2025 / receipt, needs a key / Stephen, other | earnings call 2025-05-16 | transcript f55303a3-f66a-41ca-b3d6-f0c522e4adf8 | chars 24001-24636 | segment 24

filings
total operating expenses for the quarter were $4.6 million compared to $6.7 million in the same period last year, a 32% reduction year-on-year. This reflected savings from our cost reduction program,

company_statement / Aug 14, 2026 / receipt, needs a key

executives
Cameron Reynolds CEO - receipt
David M. Kratochvil Chief Financial Officer - receipt
David Vanston Chief Financial Officer - receipt
Jason Terrell MD Chief Medical Officer - receipt
Mr. Reynolds CEO - receipt
Terig Hughes Group Chief Financial Officer - receipt
Terry Cuse Group Chief Financial Officer - receipt
familynone on file
upcoming
2026-11-12 earnings call scheduled ir
changes
2021-02-02 Chief Financial Officer, appointed sec_8k
2017-04-12 Chief Financial Officer, appointed sec_8k
2017-04-12 Chief Financial Officer, departed sec_8k
2016-01-05 Chief Medical Officer, appointed sec_8k
2015-08-17 Chief Financial Officer, appointed sec_8k
2015-08-17 Chief Financial Officer, departed sec_8k
mcp_package_hint
steadybase-$